Dynamical detection of network communities

A prominent feature of complex networks is the appearance of communities, also known as modular structures. Specifically, communities are groups of nodes that are densely connected among each other but connect sparsely with others. However, detecting communities in networks is so far a major challenge, in particular, when networks evolve in time. Here, we propose a change in the community detection approach. It underlies in defining an intrinsic dynamic for the nodes of the network as interacting particles (based on diffusive equations of motion and on the topological properties of the network) that results in a fast convergence of the particle system into clustered patterns. The resulting patterns correspond to the communities of the network. Since our detection of communities is constructed from a dynamical process, it is able to analyse time-varying networks straightforwardly. Moreover, for static networks, our numerical experiments show that our approach achieves similar results as the methodologies currently recognized as the most efficient ones. Also, since our approach defines an N-body problem, it allows for efficient numerical implementations using parallel computations that increase its speed performance

Importance of Numerical Implementation and Clustering Analysis in Force-Directed Algorithms for Accurate Community Detection

Peer reviewedPostprin

Spatiotemporal data analysis with chronological networks

The number of spatiotemporal data sets has increased rapidly in the last years, which demands robust and fast methods to extract information from this kind of data. Here, we propose a network-based model, called Chronnet, for spatiotemporal data analysis. The network construction process consists of dividing a geometric space into grid cells represented by nodes connected chronologically. Strong links in the network represent consecutive recurrent events between cells. The chronnet construction process is fast, making the model suitable to process large data sets. Using artificial and real data sets, we show how chronnets can capture data properties beyond simple statistics, like frequent patterns, spatial changes, outliers, and spatiotemporal clusters. Therefore, we conclude that chronnets represent a robust tool for the analysis of spatiotemporal data sets

Spatiotemporal data analysis with chronological networks

The amount and size of spatiotemporal data sets from different domains have been rapidly increasing in the last years, which demands the development of robust and fast methods to analyze and extract information from them. In this paper, we propose a network-based model for spatiotemporal data analysis called chronnet. It consists of dividing a geometrical space into grid cells represented by nodes connected chronologically. The main goal of this model is to represent consecutive recurrent events between cells with strong links in the network. This representation permits the use of network science and graphing mining tools to extract information from spatiotemporal data. The chronnet construction process is fast, which makes it suitable for large data sets. In this paper, we describe how to use our model considering artificial and real data. For this purpose, we propose an artificial spatiotemporal data set generator to show how chronnets capture not just simple statistics, but also frequent patterns, spatial changes, outliers, and spatiotemporal clusters. Additionally, we analyze a real-world data set composed of global fire detections, in which we describe the frequency of fire events, outlier fire detections, and the seasonal activity, using a single chronnet

An object-based visual selection model combining physical features and memory

In this paper, a new visual selection model is proposed, which combines both early visual features and object-based visual selection modulations. This model integrates three main mechanisms. The first is responsible for the segmentation of the scene allowing the identification of objects. In the second one, the average of saliency of each object is calculated for each feature considered in this work, which provides the modulation of the visual attention for one or more features. Finally, the third mechanism is responsible for building the object-saliency map, which highlights the salient objects in the scene. It will be shown that top-down modulation can overcome bottom-up saliency by selecting a known object instead of the most salient (bottom-up) and is even clear in the absence of any bottom-up clue. Several experiments with synthetic and real images are conducted and the obtained results demonstrate the effectiveness of the proposed approach for visual attention

Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry

Aims: This study aimed to assess age- and sex-related differences in management and 1-year risk for all-cause mortality and hospitalization in chronic heart failure (HF) patients. Methods and results: Of 16 354 patients included in the European Society of Cardiology Heart Failure Long-Term Registry, 9428 chronic HF patients were analysed [median age: 66 years; 28.5% women; mean left ventricular ejection fraction (LVEF) 37%]. Rates of use of guideline-directed medical therapy (GDMT) were high (angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, beta-blockers and mineralocorticoid receptor antagonists: 85.7%, 88.7% and 58.8%, respectively). Crude GDMT utilization rates were lower in women than in men (all differences: P\ua0 64 0.001), and GDMT use became lower with ageing in both sexes, at baseline and at 1-year follow-up. Sex was not an independent predictor of GDMT prescription; however, age >75 years was a significant predictor of GDMT underutilization. Rates of all-cause mortality were lower in women than in men (7.1% vs. 8.7%; P\ua0=\ua00.015), as were rates of all-cause hospitalization (21.9% vs. 27.3%; P\ua075 years. Conclusions: There was a decline in GDMT use with advanced age in both sexes. Sex was not an independent predictor of GDMT or adverse outcomes. However, age >75 years independently predicted lower GDMT use and higher all-cause mortality in patients with LVEF 6445%

Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

[Abstract] Aims. Guidelines recommend down-titration of loop diuretics (LD) once euvolaemia is achieved. In outpatients with heart failure (HF), we investigated LD dose changes in daily cardiology practice, agreement with guideline recommendations, predictors of successful LD down-titration and association between dose changes and outcomes. Methods and results. We included 8130 HF patients from the ESC-EORP Heart Failure Long-Term Registry. Among patients who had dose decreased, successful decrease was defined as the decrease not followed by death, HF hospitalization, New York Heart Association class deterioration, or subsequent increase in LD dose. Mean age was 66±13 years, 71% men, 62% HF with reduced ejection fraction, 19% HF with mid-range ejection fraction, 19% HF with preserved ejection fraction. Median [interquartile range (IQR)] LD dose was 40 (25–80) mg. LD dose was increased in 16%, decreased in 8.3% and unchanged in 76%. Median (IQR) follow-up was 372 (363–419) days. Diuretic dose increase (vs. no change) was associated with HF death [hazard ratio (HR) 1.53, 95% confidence interval (CI) 1.12–2.08; P = 0.008] and nominally with cardiovascular death (HR 1.25, 95% CI 0.96–1.63; P = 0.103). Decrease of diuretic dose (vs. no change) was associated with nominally lower HF (HR 0.59, 95% CI 0.33–1.07; P = 0.083) and cardiovascular mortality (HR 0.62 95% CI 0.38–1.00; P = 0.052). Among patients who had LD dose decreased, systolic blood pressure [odds ratio (OR) 1.11 per 10 mmHg increase, 95% CI 1.01–1.22; P = 0.032], and absence of (i) sleep apnoea (OR 0.24, 95% CI 0.09–0.69; P = 0.008), (ii) peripheral congestion (OR 0.48, 95% CI 0.29–0.80; P = 0.005), and (iii) moderate/severe mitral regurgitation (OR 0.57, 95% CI 0.37–0.87; P = 0.008) were independently associated with successful decrease. Conclusion. Diuretic dose was unchanged in 76% and decreased in 8.3% of outpatients with chronic HF. LD dose increase was associated with worse outcomes, while the LD dose decrease group showed a trend for better outcomes compared with the no-change group. Higher systolic blood pressure, and absence of (i) sleep apnoea, (ii) peripheral congestion, and (iii) moderate/severe mitral regurgitation were independently associated with successful dose decrease

Why Are Outcomes Different for Registry Patients Enrolled Prospectively and Retrospectively? Insights from the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).

Background: Retrospective and prospective observational studies are designed to reflect real-world evidence on clinical practice, but can yield conflicting results. The GARFIELD-AF Registry includes both methods of enrolment and allows analysis of differences in patient characteristics and outcomes that may result. Methods and Results: Patients with atrial fibrillation (AF) and ≥1 risk factor for stroke at diagnosis of AF were recruited either retrospectively (n = 5069) or prospectively (n = 5501) from 19 countries and then followed prospectively. The retrospectively enrolled cohort comprised patients with established AF (for a least 6, and up to 24 months before enrolment), who were identified retrospectively (and baseline and partial follow-up data were collected from the emedical records) and then followed prospectively between 0-18 months (such that the total time of follow-up was 24 months; data collection Dec-2009 and Oct-2010). In the prospectively enrolled cohort, patients with newly diagnosed AF (≤6 weeks after diagnosis) were recruited between Mar-2010 and Oct-2011 and were followed for 24 months after enrolment. Differences between the cohorts were observed in clinical characteristics, including type of AF, stroke prevention strategies, and event rates. More patients in the retrospectively identified cohort received vitamin K antagonists (62.1% vs. 53.2%) and fewer received non-vitamin K oral anticoagulants (1.8% vs . 4.2%). All-cause mortality rates per 100 person-years during the prospective follow-up (starting the first study visit up to 1 year) were significantly lower in the retrospective than prospectively identified cohort (3.04 [95% CI 2.51 to 3.67] vs . 4.05 [95% CI 3.53 to 4.63]; p = 0.016). Conclusions: Interpretations of data from registries that aim to evaluate the characteristics and outcomes of patients with AF must take account of differences in registry design and the impact of recall bias and survivorship bias that is incurred with retrospective enrolment. Clinical Trial Registration: - URL: http://www.clinicaltrials.gov . Unique identifier for GARFIELD-AF (NCT01090362)